Ultragenyx Pharmaceutical Ownership | Who Owns Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical Ownership Summary
Ultragenyx Pharmaceutical is owned by 95.73% institutional investors, 3.14% insiders, and 1.13% retail investors. Vanguard group is the largest institutional shareholder, holding 10.51% of RARE shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 3.04% of its assets in Ultragenyx Pharmaceutical shares.
RARE Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Ultragenyx Pharmaceutical | 95.73% | 3.14% | 1.13% |
| Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
| Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vanguard group | 10.03M | 10.51% | $422.17M |
| Blackrock | 5.60M | 6.65% | $230.30M |
| Blackrock funding, inc. /de | 6.26M | 6.35% | $227.47M |
| Sands capital management | 3.94M | 4.01% | $143.39M |
| State street | 2.70M | 3.20% | $110.85M |
| Baker bros. advisors lp | 2.77M | 2.82% | $100.82M |
| Price t rowe associates inc /md/ | 2.51M | 2.63% | $105.70M |
| Wellington management group llp | 2.46M | 2.57% | $103.39M |
| Clearbridge investments | 2.32M | 2.43% | $97.70M |
| Suvretta capital management | 2.28M | 2.31% | $82.83M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Cutter capital management, lp | 406.80K | 7.01% | $17.11M |
| Eagle health investments lp | 627.60K | 6.47% | $26.40M |
| Superstring capital management lp | 130.42K | 5.61% | $4.74M |
| Rock springs capital management lp | 1.39M | 3.15% | $50.58M |
| Blue owl capital lp | 255.24K | 3.00% | $9.28M |
| Privium fund management b.v. | 251.60K | 2.63% | $10.31M |
| First light asset management | 547.90K | 2.58% | $19.92M |
| Suvretta capital management | 2.28M | 2.50% | $82.83M |
| Bioimpact capital | 395.70K | 2.49% | $14.39M |
| Deep track capital, lp | 1.35M | 1.57% | $49.09M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Baker bros. advisors lp | 2.77M | 0.98% | 1.20M |
| Norges bank | 961.79K | 0.01% | 961.79K |
| Assenagon asset management | 1.16M | 0.06% | 947.87K |
| Farallon capital management | 898.00K | 0.14% | 898.00K |
| First trust advisors lp | 544.20K | 0.02% | 527.18K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Wellington management group llp | 2.46M | 0.02% | -1.71M |
| Aqr capital management | 280.55K | 0.02% | -763.83K |
| Adage capital partners gp | 1.53M | 0.09% | -619.53K |
| Price t rowe associates inc /md/ | 2.51M | 0.01% | -556.23K |
| Avoro capital advisors | 330.00K | 0.21% | -500.00K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 961.79K | 0.01% | 961.79K | $40.46M |
| Farallon capital management | 898.00K | 0.14% | 898.00K | $32.65M |
| Frontier capital management | 525.46K | 0.18% | 525.46K | $19.11M |
| Perceptive advisors | 270.00K | 0.36% | 270.00K | $9.82M |
| Bank of nova scotia | 241.99K | 0.02% | 241.99K | $8.80M |
Sold Out
| Holder | Change |
|---|---|
| Mather group, llc. | -2.00 |
| Concourse financial group securities | -3.00 |
| True wealth design | -5.00 |
| Caitlin john | -5.00 |
| Clearstead advisors | -5.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 338 | 6.29% | 94,259,190 | 8.19% | 95 | 1.17% | 178 | 10.56% | 100 | -2.91% |
| Mar 31, 2025 | 319 | -4.20% | 88,821,804 | 1.51% | 92 | 1.10% | 161 | -5.29% | 104 | -4.59% |
| Dec 31, 2024 | 195 | -38.87% | 51,382,783 | -40.24% | 53 | 0.66% | 96 | -43.86% | 71 | -24.47% |
| Sep 30, 2024 | 317 | 13.21% | 85,943,715 | -2.53% | 89 | 0.82% | 172 | 4.88% | 93 | 20.78% |
| Jun 30, 2024 | 277 | -0.72% | 88,159,116 | 11.50% | 104 | 1.10% | 163 | 7.95% | 75 | -5.06% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard US Total Market Shares ETF | 2.81M | 3.04% | 92.60K |
| Vanguard Total Stock Mkt Idx Inv | 2.81M | 2.92% | -59.32K |
| Sands Capital Select Growth TE Inst EQ | 2.39M | 2.53% | -222.05K |
| Vanguard Small Cap Index | 2.18M | 2.26% | -15.86K |
| Vanguard Explorer Inv | 2.03M | 2.15% | 30.03K |
| Hartford MidCap Y | 1.28M | 1.39% | -24.56K |
| JPMorgan Mid Cap Growth I | 1.23M | 1.30% | 210.11K |
| JPM US Mid Cap Growth-Composite | 1.23M | 1.30% | 1.23M |
| Vanguard Small Cap Growth Index Inv | 1.23M | 1.28% | -2.51K |
| DWS Vermögensbildungsfonds I LD | 1.18M | 1.22% | 4.00 |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Sep 05, 2025 | Huizenga Theodore Alan | SVP, Chief Accounting Officer | Sell | $2.64K |
| Jun 20, 2025 | Sanders Corazon (Corsee) D. | - | Sell | $89.92K |
| May 05, 2025 | Crombez Eric | EVP and Chief Medical Officer | Sell | $20.40K |
| Apr 21, 2025 | Crombez Eric | EVP and Chief Medical Officer | Sell | $8.50K |
| Mar 06, 2025 | Horn Howard | Chief Financial Officer | Sell | $72.11K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | 2 |
| 2025 Q1 | - | 11 |
| 2024 Q4 | - | 3 |
| 2024 Q3 | - | 4 |
| 2024 Q2 | - | 4 |
RARE Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools